Mega Lifesciences Public Company Limited (MEGA.BK) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · Thailand · ISIN TH4984010009

Price
36.00 THB
Market cap
31.39 bn THB
P/E (2025)
16.42
P/S (2025)
2.22
Dividend yield
4.58 %
Net margin
13.51 %
Return on equity (ROE)
18.72 %
Return on assets (ROA)
11.95 %

Mega Lifesciences Public Company Limited financials

Fiscal year20242025
Revenue15.34 bn THB14.15 bn THB
Gross profit7.75 bn THB7.27 bn THB
Operating income3.37 bn THB2.90 bn THB
EBIT2.39 bn THB2.46 bn THB
Net income2.01 bn THB1.91 bn THB
Diluted EPS – continuing operations2.31 THB2.19 THB

Full history since 2010, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Mega Lifesciences Public Company Limited

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It offers wellness and nutrition products, including medical and sports nutrition, general well-being, vitamins, probiotics, herbal medicines, and cough and cold medicines, as well as hair, kid's, men's, and women's care products; and various health concerns products, such as allergy, bone and joint, gut, liver, diabetic, eye, heart, brain, sleep and anxiety, pain, and skin care, as well as blood circulation and memory. The company also provides prescription medicines for anti-allergic, anti-infective, cardiovascular system, central nervous system, dermatology, diabetes, gastrointestinal, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology areas under the MEGA We care brand name. In addition, it offers logistical and marketing services for trading and sale of goods manufactured by third parties comprising warehouse management, collections, and value-added services; natural and plant-based health foods; digital support solutions; and operation of wellness center. Further, the company is involved in social enterprise; and software design, development, and other services. It sells its products in in Southeast Asia, Sub-Saharan Africa, Australia, Europe, and South America. Mega Lifesciences Public Company Limited was incorporated in 1982 and is headquartered in Bangkok, Thailand.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 03.11.2026. Details in the risk notice.